BioLineRx Ltd.

BLRX

$2.72

+1.12%

N/A+$0.03

Healthcare

Biotechnology

NASDAQ

Active Trading

BioLineRx Ltd., an Israeli biopharmaceutical firm established in 2003 and based in Hevel Modi'in, focuses its clinical-stage development efforts primarily on oncology. ...

C-Suite Executives

(0)

The C-suite executives form a cohesive leadership team driving the company's financial strategy and innovation.

Key Team Members

No executives available for this level

Loading executive datasets...

Founder / CEO

C-Level

Board

Director / Board

Other

Key Executives

Name	Title	Compensation	Gender	Year Born	Status
Philip A. Serlin	Chief Executive Officer	USD 560,000		1960	Active
Ella Sorani	Chief Development Officer	USD 386,000	—	1968	Active
Mali Zeevi	Chief Financial Officer	USD 348,000		1976	Active
John Lacey	Head of Corporation Communications & Investor Relations	—		—	Active
Raziel Fried	Treasurer & Budgetary Control Director	—		—	Active

Executive Compensation

(deduped by latest filing date per person-year)

Filing Date	Year	Name	Position	Level	Salary	Bonus	Stock Award	Option Award	Incentive	Other	Total

Total Compensation Trend

Sum of disclosed compensation by year (USD million)

Key Roles Compensation Lines

Top founder/C-level executives over time (USD million)

Supply Chain of BLRX

RELATIONS

Upstream

WuXi AppTec Co., Ltd.HKEx:2359Almac Pharma Services (Almac Group)Innovative Pharmaceutical Concepts (IPC), Inc.Bachem Holding AGSIX:BANBCordenPharma

Downstream

Ayrmid Ltd. / Gamida Cell Ltd.OTC:GMDAQGuangzhou Gloria Biosciences Co., Ltd. (GloriaBio)Perrigo Company plc (via Omega Pharma acquisition)NYSE:PRGO GenFleet Therapeutics (Shanghai) Inc.HKEx:2595Hemispherian AS / Tetragon Biosciences Ltd.University of Texas MD Anderson Cancer Center

Proxies

Gamida Cell Ltd.OTC:GMDAQ RedHill Biopharma Ltd.NASDAQ:RDHL WuXi AppTec Co., Ltd.HKEx:2359 Purple Biotech Ltd.NASDAQ:PPBT

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer